about
Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activationIncreased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseasesPhosphodiesterase 4-targeted treatments for autoimmune diseasesUse of antibiotics in the treatment of Crohn's disease‘Global warming’ to Mycobacterium avium subspecies paratuberculosisPrimary treatment of Crohn’s disease: combined antibiotics taking center stageCrohn's disease: an immune deficiency stateInnate immunity in inflammatory bowel disease: a disease hypothesisEtrolizumab for induction of remission in ulcerative colitisEtrolizumab for induction of remission in ulcerative colitisAnti-IL-17 monoclonal antibody for induction of remission in Crohn's diseaseInterleukin-11 for induction of remission in Crohn's diseaseHelminth therapy (worms) for induction of remission in inflammatory bowel diseaseHelminths for induction of remission in inflammatory bowel diseaseCyclosporine A for induction of remission in severe ulcerative colitisGRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cellsRELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosaCCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flowVanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activityReduced Paneth cell alpha-defensins in ileal Crohn's diseaseInflammatory bowel disease reveals the kinase activity of KSR1Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's diseaseTherapeutic faecal microbiota transplantation: current status and future developmentsLoci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel diseaseGenome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisGenome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease lociA proof of concept study establishing Necator americanus in Crohn's patients and reservoir donorsA dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseNanoparticles: pharmacological and toxicological significanceFunctional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivariusRetarded release phosphatidylcholine benefits patients with chronic active ulcerative colitisDysbiosis in inflammatory bowel diseaseFlavonoids in Inflammatory Bowel Disease: A ReviewGastrointestinal stem cells in health and disease: from flies to humansRole of antibiotics for treatment of inflammatory bowel diseaseBody Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisNanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseMesalazine preparations for the treatment of ulcerative colitis: Are all created equal?Endoscopic Therapy in Inflammatory Bowel DiseasesMitochondrial dysfunction in inflammatory bowel disease
P2860
Q21090037-556D9876-009F-458D-BBD8-964036C2B3E7Q21090656-8761BCBD-F002-4773-99A3-57C755504E7DQ21245284-F3D70B6B-B134-469A-9D9F-80D97479BEB1Q22241216-8587DEB0-5D18-41D3-BD67-BBB1548DB2B4Q22241305-E7482CB4-B822-44E2-B2BB-F9B86105D272Q22241483-21FF87FE-226A-435E-9213-7D5CB4AF50F5Q22252579-55F9F0AF-3687-4C77-8D86-224163D83DBCQ22252859-5EC58628-C82F-42B3-9254-5080FD79332CQ24186788-413E4D19-CE25-40DC-B97A-E784774A397AQ24187269-754D057B-4CDD-4770-9C8C-230AAF97BB59Q24200202-EF879735-825F-4C9B-ACC7-CCD1ECD0D1A7Q24200762-06AA933C-A1B9-43BB-A83C-FE77A8090365Q24201067-081E3C63-03A2-40C2-9AD1-0DC985127E8BQ24234013-0E6CF786-774A-4B73-9B1E-71DABECB31F3Q24245067-26E703FC-8BA6-41EB-833E-AE6273C23942Q24297555-E0B94137-348E-4420-82AC-0FD4BBB81600Q24305977-A2F3FF08-0050-4389-8A79-35818A531BEBQ24318873-F45D4247-C477-4B2E-B298-EEAB3B72AD32Q24322799-160CE7F5-1E0D-40C6-8D4F-B3877A70F8A3Q24538724-0659B2E4-6399-4010-8DAA-81B14EC17CA1Q24562733-7D4CA8ED-4192-4D9F-9EF7-BD0677859D68Q24617260-CFC902B4-F17C-4493-BDF3-DBD2D6F04378Q24629302-B96CEC6B-80B1-444A-82BE-EA4D2363608DQ24646902-35030422-A7D0-48E5-BA7D-3390065216E2Q24656576-54273580-5924-4829-9430-3FC3386A00F0Q24670061-51F7FDF7-91B4-4CA2-887E-93AD8C41D39FQ24680047-99E649F7-968B-4838-8F6B-84C6E753B1F6Q24680126-FA0929F5-F2EC-4B3A-9A1E-691B9D9F8A59Q24681563-55B18D99-FFF5-49F8-ACDD-DE285FD381B1Q24682955-5E6D5D01-D3B8-49FD-B689-70C5C90AFF81Q24685584-97A0A615-4B4A-4609-A20A-CFA4986E6DCEQ24685931-6CD97011-E7EB-40AA-944F-48E10C18FF27Q26748883-E052D2D3-801D-4566-8C1E-092E353B0B2BQ26750514-97451D8A-7214-4FA7-8812-DEF17C46AFA0Q26774552-64B110FA-5EE5-4973-A192-0CC13583E4BCQ26776419-452DB91A-C198-4002-9B31-47A89BD7202CQ26777400-6B584EC6-F277-441C-92A2-46406AF15FDFQ26777634-63676BC7-ED8F-4537-9143-8F74CBCA1CA7Q26777718-FC9F7FE0-8E2F-45AC-8BB8-8EA556F2ECFEQ26781311-2C576440-949B-495E-9934-D137C177139D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inflammatory Bowel Disease
@ast
Inflammatory Bowel Disease
@en
Inflammatory Bowel Disease
@nl
مرض معوي التهابي
@ar
type
label
Inflammatory Bowel Disease
@ast
Inflammatory Bowel Disease
@en
Inflammatory Bowel Disease
@nl
مرض معوي التهابي
@ar
altLabel
Inflammatory bowel disease
@en
prefLabel
Inflammatory Bowel Disease
@ast
Inflammatory Bowel Disease
@en
Inflammatory Bowel Disease
@nl
مرض معوي التهابي
@ar
P3181
P356
P1476
Inflammatory Bowel Disease
@en
炎症性肠病
@zh
P2093
Daniel K. Podolsky
P304
P3181
P356
10.1056/NEJMRA020831
P407
P577
2002-08-08T00:00:00Z